J Korean Cancer Assoc.  1998 Apr;30(2):242-252.

Germline Mutation of BRCA2 Gene in Korean Breast / Ovarian Cancer Families

Affiliations
  • 1Korean Hereditary Tumor Registry, Cancer Research Institute.
  • 2Department of Surgery, Seoul National University College of Medicine.
  • 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine.
  • 4Department of Surgery, Hallym University College of Medicine.
  • 5Diamond Breast Clinic.
  • 6Department of Surgery, Korea Cancer Center Hospital.
  • 7Department of Surgery, Kangnam General Hospital Public Corporation.
  • 8Dr. Oh's Breast Clinic.
  • 9Department of Internal Medicine, Ehwa Woman's University College of Medicine.
  • 10Department of Surgery, College of Medicine, Inha University.

Abstract

PURPOSE
Recent discovery of BRCA1 and BRCA2 genes has made it possible to perform presymptomatic diagnosis in hereditary breast/ovarian cancer families. We have previously reported germline mutations of the BRCA1 gene in Korean hereditary breast/ovarian cancer families. In that study two out of 13 families were found to have germline mutations in BRCA1 gene. One was a nonsense mutation in codon 1815, and the other was a frameshift mutation due to 2 base-pair deletion in codon 1701 of BRCA1 gene. This study was intended to identify germline mutations of the BRCA2 gene in Korean breast/ovarian cancer families.
MATERIALS AND METHODS
Peripheral blood DNA was obtained from 10 breast cancer patients registered at the Korean Hereditary Tumor Registry with positive family history of breast and/or ovarian cancer. Exons 11 and 27 of the BRCA2 gene(together accounting for 50% of the coding region of the BRCA2 gene) were amplified by polymerase chain reaction(PCR) and screened for mutations by in vitro transcription/translation method. For confirmation of the mutations, automatic sequencing of the PCR products displaying abnormal truncated protein bands was perfomed. RESULT: We identified an abnormal truncated protein in the exon 11 of the BRCA2 gene from a member of hereditary breast cancer family, SNU-B4. Sequencing analysis revealed a 4 bp deletion in codons 1248-49 of the exon 11, resulting in frameshift that led to premature stop codon and truncation of the protein product.
CONCLUSION
We have identified a germline mutation from a Korean hereditary breast cancer family. So far only one case of the same mutation has been registered in Database of BRCA2 mutation (BIC) by a commercial genetic diagnosis company, Myriad Genetics, Inc. Identification of the germline mutation in BRCA2 gene should aid in the accurate presymptomatic diagnosis of the at-risk members in this family.

Keyword

BRCA2 gene; Protein truncation test(PTT); Germline mutation

MeSH Terms

Breast Neoplasms
Breast*
Clinical Coding
Codon
Codon, Nonsense
Diagnosis
DNA
Exons
Frameshift Mutation
Genes, BRCA1
Genes, BRCA2*
Genetics
Germ-Line Mutation*
Humans
Ovarian Neoplasms*
Polymerase Chain Reaction
Codon
Codon, Nonsense
DNA
Full Text Links
  • JKCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr